Innate Immunity Evasion by Dengue Virus
TL;DR: The ability of the NS5 protein to bind and degrade STAT2 contributes to the limited host tropism of DENV to humans and non-human primates.
read more
Abstract: For viruses to productively infect their hosts, they must evade or inhibit important elements of the innate immune system, namely the type I interferon (IFN) response, which negatively influences the subsequent development of antigen-specific adaptive immunity against those viruses. Dengue virus (DENV) can inhibit both type I IFN production and signaling in susceptible human cells, including dendritic cells (DCs). The NS2B3 protease complex of DENV functions as an antagonist of type I IFN production, and its proteolytic activity is necessary for this function. DENV also encodes proteins that antagonize type I IFN signaling, including NS2A, NS4A, NS4B and NS5 by targeting different components of this signaling pathway, such as STATs. Importantly, the ability of the NS5 protein to bind and degrade STAT2 contributes to the limited host tropism of DENV to humans and non-human primates. In this review, we will evaluate the contribution of innate immunity evasion by DENV to the pathogenesis and host tropism of this virus.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
•Journal Article
Dengue in India
TL;DR: The extent of work done by various groups of scientists in India on various problems of dengue disease is reviewed, finding a lot remain to be achieved for creating an impact.
Diverse intracellular pathogens activate Type III Interferon expression from peroxisomes
Charlotte Odendall,Evelyn Dixit,Fabrizia Stavru,Hélène Bierne,Kate M. Franz,Ann Fiegen,Steeve Boulant,Lee Gehrke,Pascale Cossart,Jonathan C. Kagan +9 more
TL;DR: It is revealed that the process of intestinal epithelial cell differentiation upregulates peroxisome biogenesis and promotes robust type III interferon responses in human cells, highlighting the importance of different intracellular organelles in specific innate immune responses.
345
Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection.
Sebastian Aguirre,Priya Luthra,Maria Teresa Sánchez-Aparicio,Ana M. Maestre,Jenish R. Patel,Francise Lamothe,Anthony C. Fredericks,Shashank Tripathi,Tongtong Zhu,Jessica Pintado-Silva,Laurence G. Webb,Dabeiba Bernal-Rubio,Alexander Solovyov,Benjamin Greenbaum,Viviana Simon,Christopher F. Basler,Lubbertus C. F. Mulder,Adolfo García-Sastre,Ana Fernandez-Sesma +18 more
TL;DR: It is reported that the DENV NS2B protease cofactor targets the DNA sensor cyclic GMP-AMP synthase for lysosomal degradation to avoid the detection of mitochondrial DNA during infection and results in the inhibition of type I interferon production in the infected cell.
342
Diverse intracellular pathogens activate type III interferon expression from peroxisomes
Charlotte Odendall,Evelyn Dixit,Fabrizia Stavru,Hélène Bierne,Kate M Franz,Ann Fiegen Durbin,Steeve Boulant,Lee Gehrke,Pascale Cossart,Jonathan C. Kagan +9 more
TL;DR: It is revealed that the process of intestinal epithelial cell differentiation upregulates peroxisome biogenesis and promotes robust type III interferon responses in human cells, highlighting the importance of different intracellular organelles in specific innate immune responses.
Biochemistry and Molecular Biology of Flaviviruses
Nicholas J. Barrows,Nicholas J. Barrows,Rafael K. Campos,Rafael K. Campos,Kuo-Chieh Liao,K. Reddisiva Prasanth,Ruben Soto-Acosta,Shih Chia Yeh,Geraldine Schott-Lerner,Julien Pompon,Julien Pompon,October M. Sessions,Shelton S. Bradrick,Mariano A. Garcia-Blanco,Mariano A. Garcia-Blanco +14 more
TL;DR: This review examines the molecular biology of flaviviruses touching on the structure and function of viral components and how these interact with host factors, and highlights the role of a noncoding RNA produced by flavIViruses to impair antiviral host immune responses.
280
References
NS5 of dengue virus mediates STAT2 binding and degradation.
TL;DR: It is demonstrated here that the polymerase of the virus, NS5, binds to STAT2 and is necessary and sufficient for its reduced level of expression, and it is shown that the degradation of but not binding toSTAT2 is dependent on the expression of the polymer enzyme in the context of a polyprotein that undergoes proteolytic processing for NS5 maturation.
426
Organelle-Like Membrane Compartmentalization of Positive-Strand RNA Virus Replication Factories
TL;DR: Understanding is growing of the ultrastructure and function of organelle-like RNA replication factories, providing substantial new insights into the organization, coordination, and potential control of crucial processes in virus replication.
423
CLEC5A is critical for dengue-virus-induced lethal disease.
Szu Ting Chen,Yi-Ling Lin,Ming Ting Huang,Ming Fang Wu,Shih-Chin Cheng,Huan Yao Lei,Chien-Kuo Lee,Tzyy-Wen Chiou,Chi-Huey Wong,Shie-Liang Hsieh,Shie-Liang Hsieh,Shie-Liang Hsieh +11 more
TL;DR: The observation that blockade of CLEC5A-mediated signalling attenuates the production of proinflammatory cytokines by macrophages infected with DV offers a promising strategy for alleviating tissue damage and increasing the survival of patients suffering from d Dengue haemorrhagic fever and dengue shock syndrome, and possibly even other virus-induced inflammatory diseases.
415
Structure and function of flavivirus NS5 methyltransferase.
Yangsheng Zhou,Debashish Ray,Yiwei Zhao,Hongping Dong,Suping Ren,Suping Ren,Zhong Li,Yi Guo,Kristen A. Bernard,Kristen A. Bernard,Pei Yong Shi,Pei Yong Shi,Hongmin Li,Hongmin Li +13 more
TL;DR: The results demonstrate that the N-7 methylation activity is essential for the WNV life cycle and, thus, methyltransferase represents a novel target for flavivirus therapy.
397
New Mouse Model for Dengue Virus Vaccine Testing
TL;DR: It is demonstrated that AG129 mice are a promising small animal model for DEN virus vaccine trials, and survival times increased following passive transfer of anti-DEN polyclonal antibody.
366
Related Papers (5)
Samir Bhatt,Peter W. Gething,Oliver J. Brady,Jane P. Messina,Andrew Farlow,Catherine L. Moyes,John M. Drake,John M. Drake,John S. Brownstein,Anne G. Hoen,Osman Sankoh,Osman Sankoh,Monica F. Myers,Dylan B. George,Thomas Jaenisch,G. R. William Wint,Cameron P. Simmons,Thomas W. Scott,Thomas W. Scott,Jeremy Farrar,Jeremy Farrar,Simon I. Hay,Simon I. Hay +22 more